Hannah Valantine

Director

Hannah Valantine (Director) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $1.7M of BBIO (25,484 sh across 2 lots, as filed), executed Feb 27.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 6 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$5.7M

shares × price, as filed

Last traded

Jul 16

Filed Jul 17

Median ADV $293.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $6.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 6 filings

Sector per market data · by filing · past 12 months

Most traded names

BBIO

BridgeBio Pharma, Inc. BBIO · 0 buys · 6 sells 6 filings CDNA

CareDx, Inc. CDNA · 0 buys · 3 sells 3 filings

Recent filings

CDNASALE CareDx, Inc. View filing → $1.0M
28,679 sh × $36.14
Exec Jul 16
Filed Jul 17 · 4:22 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $342K
5,004 sh across 2 lots
Exec Jun 22
Filed Jun 24 · 5:30 PM ET CDNASALE CareDx, Inc. View filing → $280K
12,103 sh × $23.11
Exec Jun 15
Filed Jun 16 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $624K
8,671 sh × $72.00
Exec Mar 10
Filed Mar 12 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $1.7M
25,484 sh across 2 lots
Exec Feb 27
Filed Mar 3 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $1.7M
25,484 sh × $66.07
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET CDNASALE CareDx, Inc. View filing → $203K
10,570 sh × $19.16
Exec Jun 18 2025
Filed Jun 23 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $172K
4,292 sh × $40.00
Exec Jun 10 2025
Filed Jun 11 2025 · 5:30 PM ET More filings →